Update:
View uploaded report
In previous years of this study, foliar fungicide applications with the selected products tested here provided some benefit related to improved seed quality and yield in situations where frogeye leaf spot disease pressure was present at measurable levels. Fungicides also significantly increased plant greenness and delayed senescence.
During the 2022 growing season, however, none of the treatments tested yielded significantly different than the non-treated control. This is likely due to the fact that no ratable foliar fungal diseases were present in the plots this year. Without the presence of a pathogen, fungicides have reduced odds of improving yields over non-treated plots.
Relative net profit was calculated by multiplying the bushel increase over the non-treated control by the cash market price for soybean at the time of analysis (14.60/bu for 2022) and subtracting the cost of application. A flat rate of $26.00 per acre was used for 2022 data; for plot with two applications, $52 was used. This metric, net profit, was used to compare the economics of the fungicides while accounting for yield and market prices. For the 2022 trials, this comparison yielded no significant differences. However, when compared across all seasons (2022-2023), a single fungicide application at R3 significantly increased profits by an average of $38 per acre compared to the two-pass program, which lost an average of $26 per acre.
Future work will be focused on replicating similar experiments over more plot-years to gather more data for Maryland’s unique growing conditions and to track pathogen resistance and fungicide profitability over time.